Effects of nattokinase on blood pressure: A randomized, controlled trial

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1583-1588

  Kim, Ji Young ^a   Gum, Si Nae ^a   Paik, Jean Kyung ^a,b   Lim, Hyo Hee ^a   Kim, Kyong Chol ^a,c   Ogasawara, Kazuya ^d   Inoue, Kenichi ^d   Park, Sungha ^e   Jang, Yangsoo ^a,e   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Seoul Fellowship   (South Korea)

^c Mizmedi Hospital   (South Korea)

^d Japan Bio Science Laboratory Co Ltd   (Japan)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Blood pressure; Controlled trial; Nattokinase; Randomized; Renin activity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; NATTOKINASE; PLACEBO; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENERGY EXPENDITURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; PHYSICAL ACTIVITY; PLASMA RENIN ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 55449090425     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1583     Document Type: Article

References (24)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365 (9455): 217-223.
2. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
3. Gu D, Reynolds K, Wu X, et al, InterASIA Collaborative Group: The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40: 920-927.
4. Choi KM, Park HS, Han JH, et al: Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens 2006; 24: 1515-1521.
5. Whelton PK, He J, Appel LJ, et al; National High Blood Pressure Education Program Coordinating Committee: Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288: 1882-1888.
6. Neaton JD, Grimm RH Jr, Prineas RJ, et al: Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270: 713-724.
7. Iseki K, Kimura Y, Wakugami K, et al: Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 2000; 23: 143-149.
8. Artaud-Wild SM, Connor SL, Sexton G, Connor WE: Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 1993; 88: 2771-2779.
9. Keys A, Menotti A, Aravanis C, et al: The seven countries study: 2,289 deaths in 15 years. Prev Med 1984; 13: 141.
10. Golbitz P: Traditional soy foods: processing and products. J Nutr 1995; 125 (3 Suppl): 570S-572S.
11. Fujita M, Ito Y, Hong K, Nishimuro S: Characterization of Nattokinase-degraded products from human fibrinogen or cross-linked fibrin. Fibrinolysis 1995; 9: 157.
12. Fujita M, Nomura K, Hong K, Ito Y, Asada A, Nishimuro S: Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem Biophys Res Commun 1993; 197: 1340-1347.
13. Urano T, Ihara H, Umemura K, et al: The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem 2001; 276: 24690-24696.
14. Jalil JE, Piddo AM, Cordova S, et al: Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population. Am J Hypertens 1999; 12: 697-704.
15. Christian JL, Greger JH: Nutrition for Living. San Francisco, The Benjamin/Cummings Publ Comp Inc, 1991, p 111.
16. American Dietetic Association: Handbook of Clinical Dietetics, 2nd ed, New Haven, Yale University Press, 1992, pp 5-39.
17. Suzuki Y, Kondo K, Ichise H, Tsukamoto Y, Urano T, Umemura K: Dietary supplementation with fermented soybeans suppresses intimal thickening. Nutrition 2003; 19: 261-264.
18. Suzuki Y, Kondo K, Matsumoto Y, et al: Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Life Sci 2003; 73: 1289-1298.
19. Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S: Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol Pharm Bull 1995; 18: 1387-1391.
20. Pais E, Alexy T, Holsworth RE Jr, Meiselman HJ: Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. Clin Hemorheol Microcirc 2006; 35: 139-142.
21. Maruyama M, Sumi H (eds): Effect of natto diet on blood pressure, in Basic and Clinical Aspects of Japanese Traditional Food Natto II. Japan Technology Transfer Association (JTTAS), 1998, pp 1-3.
22. Kim S, Yamamoto K: The in vivo role of renin-angiotensin system. Cell Science 1992; 8: 146-151.
23. Okamoto A, Hanagata H, Kawamura Y, Yanagida F: Antihypertensive substances in fermented soybean, natto. Plant Foods Hum Nutr 1995; 47: 39-47.
24. Kuba M, Tanaka K, Tawata S, Takeda Y, Yasuda M: Angiotensin I-converting enzyme inhibitory peptides isolated from tofuyo fermented soybean food. Biosci Biotechnol Biochem 2003; 67: 1278-1283.